Valneva SE (VALN) FCF Margin (2021 - 2026)

Valneva SE's (VALN) quarterly FCF Margin came in at 0.21% in Q1 2026, up 1282.0% year-on-year from 0.02% in Q1 2025, and up 99.74% quarter-over-quarter from 83.45% in Q4 2025.

Valneva SE (VALN) FCF Margin (2021 - 2026) Analysis & Trends

Valneva SE has disclosed FCF Margin across 6 years of filings, most recently posting 0.21% for Q1 2026.

  • FCF Margin for Q1 2026 came in at 0.21%, up 1282.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 35.17% (up 24.0% YoY), and the FY2025 annual result was 34.9%, up 1475.0% from the prior year.
  • FCF Margin came in at 0.21% for Q1 2026 at Valneva SE, up from 83.45% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 159439.25% in Q3 2023 to a low of 155057.95% in Q2 2023.
  • The 5-year median for FCF Margin is 74.05% (2024), against an average of 164.75%.
  • Across the five-year window, FCF Margin soared 15964004 bps in 2023 and slumped 15944859 bps in 2024, its largest moves.
  • Valneva SE's FCF Margin stood at 268.67% in 2022, then surged by 32 bps to 183.39% in 2023, then surged by 83 bps to 31.31% in 2024, then tumbled by 167 bps to 83.45% in 2025, then surged by 100 bps to 0.21% in 2026.
  • The last three FCF Margin figures came in at 0.21% (Q1 2026), 83.45% (Q4 2025), and 53.84% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -3.98%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 43.35%
9 Abivax 94.26 Bn 94.26 Bn - -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn -0.21%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.21%
Dec 31, 2025 -83.45%
Sep 30, 2025 -53.84%
Jun 30, 2025 -3.22%
Mar 31, 2025 -13.03%
Dec 31, 2024 -31.31%
Sep 30, 2024 -9.34%
Jun 30, 2024 -103.09%
Mar 31, 2024 -74.05%
Dec 31, 2023 -183.39%
Sep 30, 2023 159,439.25%
Jun 30, 2023 -155,057.95%
Mar 31, 2023 -63.80%
Dec 31, 2022 -268.67%
Sep 30, 2022 -200.80%
Jun 30, 2022 -384.28%
Mar 31, 2022 -108.07%
Dec 31, 2021 -680.11%
Sep 30, 2021 -131.28%
Jun 30, 2021 380.66%